These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10424768)

  • 1. Sequence-dependent antagonism between fluorouracil and paclitaxel in human breast cancer cells.
    Grem JL; Nguyen D; Monahan BP; Kao V; Geoffroy FJ
    Biochem Pharmacol; 1999 Aug; 58(3):477-86. PubMed ID: 10424768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA damage and p53 induction do not cause ZD1694-induced cell cycle arrest in human colon carcinoma cells.
    Matsui SI; Arredondo MA; Wrzosek C; Rustum YM
    Cancer Res; 1996 Oct; 56(20):4715-23. PubMed ID: 8840989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
    Menendez JA; Vellon L; Colomer R; Lupu R
    Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of cell growth by NB1011 requires high thymidylate synthase levels and correlates with p53, p21, bax, and GADD45 induction.
    Neuteboom ST; Karjian PL; Boyer CR; Beryt M; Pegram M; Wahl GM; Shepard HM
    Mol Cancer Ther; 2002 Apr; 1(6):377-84. PubMed ID: 12477050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Fluorouracil interferes with paclitaxel cytotoxicity against human solid tumor cells.
    Johnson KR; Wang L; Miller MC; Willingham MC; Fan W
    Clin Cancer Res; 1997 Oct; 3(10):1739-45. PubMed ID: 9815558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 and WAF1 are induced and Rb protein is hypophosphorylated during cell growth inhibition by the thymidylate synthase inhibitor ZD1694 (Tomudex).
    Yin MB; Voigt W; Panadero A; Vanhoefer U; Frank C; Pajovic S; Azizkhan J; Rustum YM
    Mol Pharmacol; 1997 Apr; 51(4):630-6. PubMed ID: 9106628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cells.
    Ren Q; Van Groeningen CJ; Hardcastle A; Aherne GW; Geoffroy F; Allegra CJ; Johnston PG; Grem JL
    Oncol Res; 1997; 9(2):77-88. PubMed ID: 9167189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced expression of p53 and p21WAF1/CIP1 sensitizes human breast cancer cells to paclitaxel and its combination with 5-fluorouracil.
    Johnson KR; Fan W
    Anticancer Res; 2002; 22(6A):3197-204. PubMed ID: 12530065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration sequence-dependent antitumor effects of paclitaxel and 5-fluorouracil in the human gastric cancer cell line MKN45.
    Toiyama Y; Tanaka K; Konishi N; Mohri Y; Tonouchi H; Miki C; Kusunoki M
    Cancer Chemother Pharmacol; 2006 Feb; 57(3):368-75. PubMed ID: 16075279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the induction of DNA damage, cell cycle arrest, and cell death by 5-fluorouracil and antifolates.
    Backus HH; Pinedo HM; Wouters D; Kuiper CM; Jansen G; van Groeningen CJ; Peters GJ
    Oncol Res; 2000; 12(5):231-9. PubMed ID: 11417748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence-dependent interaction of 5-fluorouracil and arabinosyl-5-azacytosine or 1-beta-D-arabinofuranosylcytosine.
    Grem JL; Allegra CJ
    Biochem Pharmacol; 1991 Jul; 42(2):409-18. PubMed ID: 1713459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced cytotoxicity with interleukin-1 alpha and 5-fluorouracil in HCT116 colon cancer cells.
    Geoffroy FJ; Allegra CJ; Sinha B; Grem JL
    Oncol Res; 1994; 6(12):581-91. PubMed ID: 7787251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity.
    Giannakakou P; Robey R; Fojo T; Blagosklonny MV
    Oncogene; 2001 Jun; 20(29):3806-13. PubMed ID: 11439344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of p21(waf1) decreases G2-M arrest and apoptosis induced by paclitaxel in human sarcoma cells lacking both p53 and functional Rb protein.
    Li W; Fan J; Banerjee D; Bertino JR
    Mol Pharmacol; 1999 Jun; 55(6):1088-93. PubMed ID: 10347252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
    Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM
    Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel sensitivity correlates with p53 status and DNA fragmentation, but not G2/M accumulation.
    Rakovitch E; Mellado W; Hall EJ; Pandita TK; Sawant S; Geard CR
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1119-24. PubMed ID: 10421546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cells.
    Guglielmi A; Aschele C; Mori A; Baldo C; Russo P; Debernardis D; Valenti M; Bruno S; Taverna M; Rosso R
    Clin Cancer Res; 1995 Nov; 1(11):1337-44. PubMed ID: 9815929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locus of the interaction among 5-fluorouracil, leucovorin, and interferon-alpha 2a in colon carcinoma cells.
    Houghton JA; Morton CL; Adkins DA; Rahman A
    Cancer Res; 1993 Sep; 53(18):4243-50. PubMed ID: 8364921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Fluorouracil enhances azidothymidine cytotoxicity: in vitro, in vivo, and biochemical studies.
    Brunetti I; Falcone A; Calabresi P; Goulette FA; Darnowski JW
    Cancer Res; 1990 Jul; 50(13):4026-31. PubMed ID: 2354452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of fluorouracil cytotoxicity by interferon-alpha and -gamma.
    Ismail A; Van Groeningen CJ; Hardcastle A; Ren Q; Aherne GW; Geoffroy F; Allegra CJ; Grem JL
    Mol Pharmacol; 1998 Feb; 53(2):252-61. PubMed ID: 9463483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.